Skip to Main content Skip to Navigation
Theses

Etude des relations entre les mutations EGFR/KRAS et les altérations de la voie p53/p14arf et caractérisation d'une nouvelle cible thérapeutique, le complexe neurotensine et son récepteur1, dans les cancers bronchiques non à petites cellules

Abstract : We have studied, in the lung adenocarcinomas bearing EGFR or KRAS mutations, TP53/p14arf status, and in the non-small cell lung cancer the contribution of Neurotensin system (NTS/NTSR1) on the tumoral progression and survival. In a series of 96 patients, TP53, KRAS and EGFR mutations were detected in 45.2 %, 15.8 % and 34.4 % of the cases, respectively. The p14arf decrease expression was observed in 57.1 % of the cases. The p53/p14arf deficit was observed in 83.3 % and 76.9% of EGFR and KRAS mutated tumors, respectively. Our results showed that the inactivation of the p53/p14arf pathway is common but not systematic in EGFR or KRAS mutated lung adenocarcinomas. Labeling of NTS and NTSR1 was found in 60.4 % of stage I (n = 139), 47% of stage II (n = 74), and 50% of stage III (n = 133) adenocarcinomas. In univariate and multivariate analysis, NTSR1 expression were significantly associated with a poor prognosis in terms of overall survival (p = 0.0081 for stage I, p = 0.0087 for stage II-III). In vivo and in vitro studies have shown that the complex NTS/NTSR1 promotes tumor progression by increasing HER2 and HER3 expression and EGFR, HER3 and HER2 activation. This latter was mediated by MMP1 activation and HB-EGF and NRG1 released. This work supports the hypothesis that complex NTS/NTSR1 actively contributes to the aggressiveness and bronchial tumor progression
Document type :
Theses
Complete list of metadata

https://tel.archives-ouvertes.fr/tel-00839459
Contributor : Theses Bupmc Connect in order to contact the contributor
Submitted on : Friday, June 28, 2013 - 10:15:55 AM
Last modification on : Sunday, June 26, 2022 - 9:41:21 AM
Long-term archiving on: : Wednesday, April 5, 2017 - 4:52:00 AM

Identifiers

  • HAL Id : tel-00839459, version 1

Citation

Mohamad Younes. Etude des relations entre les mutations EGFR/KRAS et les altérations de la voie p53/p14arf et caractérisation d'une nouvelle cible thérapeutique, le complexe neurotensine et son récepteur1, dans les cancers bronchiques non à petites cellules. Cancer. Université Pierre et Marie Curie - Paris VI, 2012. Français. ⟨NNT : 2012PAO66552⟩. ⟨tel-00839459⟩

Share

Metrics

Record views

301

Files downloads

2265